JAZZ vs SD · P/E 1988, rev $4.07B vs P/E 6.9, rev $125.3M
Jazz Pharmaceuticals PLC (JAZZ) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the JAZZ and SD stock pages for the full models.
Not investment advice.